Campbell, J., Lowe, D., & Sleeman, M. A. (2011). Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis. British journal of pharmacology, 162(7), 1470-1484. https://doi.org/10.1111/j.1476-5381.2010.01183.x
Chicago Style (17th ed.) CitationCampbell, Jamie, David Lowe, and Matthew A. Sleeman. "Developing the Next Generation of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis." British Journal of Pharmacology 162, no. 7 (2011): 1470-1484. https://doi.org/10.1111/j.1476-5381.2010.01183.x.
MLA (9th ed.) CitationCampbell, Jamie, et al. "Developing the Next Generation of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis." British Journal of Pharmacology, vol. 162, no. 7, 2011, pp. 1470-1484, https://doi.org/10.1111/j.1476-5381.2010.01183.x.